Specific structural requirements for the inhibitory effect of thapsigargin on the Ca2+ ATPase SERCA

被引:53
作者
Xu, C
Ma, HL
Inesi, G [1 ]
Al-Shawi, MK
Toyoshima, C
机构
[1] Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA
[2] Univ Virginia Syst, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA
[3] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan
关键词
D O I
10.1074/jbc.M313263200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutational analysis of amino acid residues lining the thapsigargin (TG) binding cavity at the interface of the membrane surface and cytosolic headpiece was performed in the Ca2+ ATPase (SERCA-1). Specific mutations such as F256V, I765A, and Y837A reduce not only the apparent affinity of the ATPase for TG but also the maximal inhibitory effect. The effect of mutations is dependent on the type and size of the substitute side chain, indicating that hydrophobic partitioning of TG and complementary molecular shapes are involved not only in binding but also in the inhibitory mechanism. A major factor determining the inhibitory effect of bound TG is its interference with conformational changes that are required for the progress of the ATPase cycle. Most prominent and specific is the TG interference with a wide displacement of the Phe-256 side chain that is associated with the E2 to E1.2Ca(2+) transition. The specificity of the TG inhibitory mechanism is emphasized by the finding that the F256V mutation does not interfere at all with the effect of 2,5-di-(t-butyl)-hydroquinone, which is another SERCA inhibitor bound by hydrophobic partitioning. The specificity of the inhibitory mechanism is also emphasized by the observation that within the concentration range producing total inhibition of wild-type SERCA-1, TG produces a 4-fold stimulation of the P-glycoprotein (multidrug transporter) ATPase.
引用
收藏
页码:17973 / 17979
页数:7
相关论文
共 42 条
  • [1] Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein
    Al-Shawi, MK
    Polar, MK
    Omote, H
    Figler, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) : 52629 - 52640
  • [2] ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
  • [3] The Escherichia coli F0F1 gamma M23K uncoupling mutant has a higher K-0.5 for P-i. Transition state analysis of this mutant and others reveals that synthesis and hydrolysis utilize the same kinetic pathway
    AlShawi, MK
    Ketchum, CJ
    Nakamoto, RK
    [J]. BIOCHEMISTRY, 1997, 36 (42) : 12961 - 12969
  • [4] Biochemical, cellular, and pharmacological aspects of the multidrug transporter
    Ambudkar, SV
    Dey, S
    Hrycyna, CA
    Ramachandra, M
    Pastan, I
    Gottesman, MM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 361 - 398
  • [5] Calcium - a life and death signal
    Berridge, MJ
    Bootman, MD
    Lipp, P
    [J]. NATURE, 1998, 395 (6703) : 645 - 648
  • [7] CHRISTENSEN SB, 1982, J ORG CHEM, V47, P649
  • [8] ADP-insensitive phosphoenzyme intermediate of sarcoplasmic reticulum Ca2+-ATPase has a compact conformation resistant to proteinase K, V8 protease and trypsin
    Danko, S
    Daiho, T
    Yamasaki, K
    Kamidochi, M
    Suzuki, H
    Toyoshima, C
    [J]. FEBS LETTERS, 2001, 489 (2-3): : 277 - 282
  • [9] Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer
    Denmeade, SR
    Jakobsen, CM
    Janssen, S
    Khan, SR
    Garrett, ES
    Lilja, H
    Christensen, SB
    Isaacs, JT
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (13) : 990 - 1000
  • [10] PHOSPHOLIPID ORIENTATION IN SARCOPLASMIC MEMBRANES - SPIN-LABEL ESR AND PROTON NMR STUDIES
    ELETR, S
    INESI, G
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 282 (SEP1) : 174 - &